NCT00274885 Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer Status UNKNOWN Phase PHASE4
NCT00274872 Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Status UNKNOWN Phase PHASE2/PHASE3
NCT00274859 Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer Status UNKNOWN Phase PHASE2
NCT00268463 Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer Status TERMINATED Phase PHASE3
NCT00268411 Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer Status UNKNOWN Phase PHASE3
NCT00268333 Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00268151 Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT00266097 Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer Status COMPLETED Phase PHASE1
NCT00263055 MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV Status COMPLETED Phase PHASE4
NCT00263029 Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT00262808 GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer Status COMPLETED Phase PHASE2
NCT00256321 Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma Status TERMINATED Phase PHASE2
NCT00256308 Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00256295 Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00256269 Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma Status TERMINATED Phase PHASE2
NCT00254137 Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE2